Search research articles
Contact Us
Filters
Showing results (101-110 of 151) with videos related to
Page
of 16
Sort By:
Journal of the National Cancer Institute
|
July 16, 1997
Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12
F Cavallo, P Signorelli, M Giovarelli, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 26, 1999
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin
E Di Carlo, M G Diodoro, K Boggio, et al.
International Journal of Immunopathology and Pharmacology
|
October 8, 2011
HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice
Manuela Iezzi, E Quaglino, P Cappello, et al.
Journal of the National Cancer Institute
|
October 18, 2001
1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice
C Colussi, S Fiumicino, A Giuliani, et al.
The Journal of Pathology
|
April 21, 1999
Interaction between endothelial cells and the secreted cytokine drives the fate of an IL4- or an IL5-transduced tumour
E Di Carlo, A Modesti, A Coletti, et al.
Scandinavian Journal of Immunology
|
April 27, 2002
Enhanced inhibition of tumour growth and metastasis, and induction of antitumour immunity by IL-2-IgG2b fusion protein
V Budagian, P Nanni, P L Lollini, et al.
Gene Therapy
|
January 13, 1998
Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-alpha and HSVtk: perspectives for the generation of cancer vaccines
L Santodonato, G D'Agostino, S M Santini, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
January 1, 1996
Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha
P Musiani, A Allione, A Modica, et al.
Cancer Gene Therapy
|
February 26, 1998
Characterization and tumorigenicity of human neuroblastoma cells transfected with the IL-2 gene
M V Corrias, S Basso, R Meazza, et al.
The Journal of Pathology
|
June 22, 2000
Dissimilar anti-tumour reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude mice
E Di Carlo, R Meazza, S Basso, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 151) with videos related to
Sort By:
Page
of 16
Journal of the National Cancer Institute
|
July 16, 1997
Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12
F Cavallo, P Signorelli, M Giovarelli, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 26, 1999
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin
E Di Carlo, M G Diodoro, K Boggio, et al.
International Journal of Immunopathology and Pharmacology
|
October 8, 2011
HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice
Manuela Iezzi, E Quaglino, P Cappello, et al.
Journal of the National Cancer Institute
|
October 18, 2001
1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice
C Colussi, S Fiumicino, A Giuliani, et al.
The Journal of Pathology
|
April 21, 1999
Interaction between endothelial cells and the secreted cytokine drives the fate of an IL4- or an IL5-transduced tumour
E Di Carlo, A Modesti, A Coletti, et al.
Scandinavian Journal of Immunology
|
April 27, 2002
Enhanced inhibition of tumour growth and metastasis, and induction of antitumour immunity by IL-2-IgG2b fusion protein
V Budagian, P Nanni, P L Lollini, et al.
Gene Therapy
|
January 13, 1998
Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-alpha and HSVtk: perspectives for the generation of cancer vaccines
L Santodonato, G D'Agostino, S M Santini, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
January 1, 1996
Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha
P Musiani, A Allione, A Modica, et al.
Cancer Gene Therapy
|
February 26, 1998
Characterization and tumorigenicity of human neuroblastoma cells transfected with the IL-2 gene
M V Corrias, S Basso, R Meazza, et al.
The Journal of Pathology
|
June 22, 2000
Dissimilar anti-tumour reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude mice
E Di Carlo, R Meazza, S Basso, et al.
Page
of 16